SavedAdd your journal

Journals / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 4

C-Reactive Protein-Albumin Ratio’s Prognostic Importance in Esophageal Cancer for Survival

Sahin LACİN
Melek Karakurt ERYILMAZ
Fatma Yalcin MÜSRİ
Ahmet Erkan BİLİCİ
Ozgur Cem MÜSRİ
Selver İŞIK
Eyup Halit YARDIMCI
Pages
501–505
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The relationship between CAR and overall survival (OS) isevaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study is designed to show the importance of C-reactive protein (CRP) to albumin ratio (CAR) in esophageal cancer (EC) prognosis.Methods: 39 patients with stage I-III EC, who were treated between 2012–2019 in Erzurum Regional Training and Research Hospital Oncology Clinic, are scanned retrospectively.
📊
Key Findings & Data:The relationship between CAR and overall survival (OS) isevaluated.
💡
Conclusion & Impact:CAR cut-off value is calculated as 0.5; the patients are categorized and analyzed in two groups as
🔬Design:Research Article
📍Scope:2012–2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study is designed to show the importance of C-reactive protein (CRP) to albumin ratio (CAR) in esophageal cancer (EC) prognosis.Methods: 39 patients with stage I-III EC, who were treated between 2012–2019 in Erzurum Regional Training and Research Hospital Oncology Clinic, are scanned retrospectively. The relationship between CAR and overall survival (OS) isevaluated. CAR cut-off value is calculated as 0.5; the patients are categorized and analyzed in two groups as

🔖

Cite This Article

LACİN, S., ERYILMAZ, M. K., MÜSRİ, F. Y., BİLİCİ, A. E., MÜSRİ, O. C., İŞIK, S., YARDIMCI, E. H. (2022). C-Reactive Protein-Albumin Ratio’s Prognostic Importance in Esophageal Cancer for Survival. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 4, 501–505. https://ajindex.com/articles/508686

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nakamura M, Iwahashi M, Nakamori M, Ojima T, Katsuda M, Iida T, et al. A new prognostic score for the survial of patients with esophageal squamous cell carcinoma. Surg Today. 2014;44:875–83
  2. Liu F, Tian T, Xia LL, Ding Y, Cormier RT, He Y. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update. Dis Esophagus 2017;30:1–9
  3. Mariette C, De Botton ML, Piessen G. Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice?. Ann Surg Oncol 2012;19:2128–34
  4. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw 2015;13:194–227
  5. Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 1998;34:503–9
  6. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 2010;9:69
  7. Wong VK, Malik HZ, Hamady ZZ, Al-Mukhtar A, Gomez D, Prasad KR, et al. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer 2007;96:222–5
  8. Kinoshita A, Onoda H, Takano K, Imai N, Saeki C, Fushiya N, et al. Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma. Med Oncol 2012;29:2800–8
  9. Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang J, et al. Prognostic value of PLR in various cancers: A meta-analysis. PLoS One 2014;9:e101119
  10. Kawashima M, Murakawa T, Shinozaki T, Ichinose J, Hino H, Konoeda C, et al. Significance of the glasgow prognostic score as a prognostic indicator for lung cancer surgery. Interact Cardiovasc Thorac Surg 2015;21:637–43
  11. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju124
  12. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. The C-reactive protein/albumin ratio, a novel inflammationbased prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 2015;22:803–10
  13. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014;15:e493–503.